Zacks Research upgraded shares of Astera Labs (NASDAQ:ALAB – Free Report) from a hold rating to a strong-buy rating in a research note released on Tuesday,Zacks.com reports.
ALAB has been the subject of a number of other reports. Roth Capital reiterated a “buy” rating and set a $450.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Needham & Company LLC raised their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Jefferies Financial Group boosted their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Finally, Rothschild & Co Redburn started coverage on shares of Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average target price of $325.25.
Check Out Our Latest Stock Report on Astera Labs
Astera Labs Price Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the firm posted $0.44 earnings per share. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts expect that Astera Labs will post 2.7 earnings per share for the current fiscal year.
Insider Activity
In other news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 111,214 shares of the firm’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $216.89, for a total value of $24,121,204.46. Following the completion of the transaction, the chief executive officer owned 3,817,969 shares of the company’s stock, valued at approximately $828,079,296.41. The trade was a 2.83% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,256,894 shares of company stock worth $362,763,135. Company insiders own 10.40% of the company’s stock.
Hedge Funds Weigh In On Astera Labs
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Glenmede Trust Co. NA increased its holdings in Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after acquiring an additional 51 shares during the last quarter. Keating Financial Advisory Services Inc. purchased a new position in shares of Astera Labs during the second quarter valued at about $25,000. Lido Advisors LLC grew its position in shares of Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares in the last quarter. Goldstein Advisors LLC increased its holdings in shares of Astera Labs by 5.8% in the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock worth $268,000 after purchasing an additional 88 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new position in Astera Labs during the second quarter valued at approximately $43,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Brokerages assign ALAB a consensus “Moderate Buy” rating, indicating generally favorable views among covering analysts. Astera Labs Given Consensus Recommendation of Moderate Buy
- Positive Sentiment: Northland Securities substantially raised its earnings forecasts, including FY2026 EPS to $2.75 from $1.82 and FY2027 EPS to $5.43 from $2.26. The revisions reflect expectations for strong growth in Astera’s AI connectivity business. Northland Securities Earnings Estimate Revisions
- Positive Sentiment: Analyst commentary highlights record growth, rising PCIe 6 demand and an expanding connectivity portfolio, potentially helping Astera compete with Marvell and Credo. ALAB Benefits From PCIe Demand
- Positive Sentiment: A bullish Seeking Alpha analysis sees Astera’s shift toward integrated, rack-level connectivity as an inflection point. Its Scorpio high-radix fabric switch could become the company’s largest revenue source, increase average selling prices and support cross-selling. The article assigns a Buy rating and a $370 price target. Astera Labs AI Fabric Inflection
- Positive Sentiment: AMD’s planned Helios rack-scale AI systems could benefit Astera as an ecosystem supplier, adding another potential demand driver beyond direct accelerator vendors. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
- Neutral Sentiment: Despite raising its earnings estimates, Northland Securities maintained a “Market Perform” rating, signaling that strong growth expectations may already be reflected in ALAB’s valuation.
- Negative Sentiment: Astera Labs trades at a very high valuation, with a reported P/E ratio near 158 and a beta of 3.84. This leaves the stock particularly sensitive to profit-taking, changes in AI spending expectations and broader technology-sector weakness.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- Franco-Nevada Earnings: Gold Is Rallying, But Does the Stock Even Care?
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
